Home/Filings/4/0001415889-25-013978
4//SEC Filing

Busque Philippe 4

Accession 0001415889-25-013978

CIK 0001831915other

Filed

May 20, 8:00 PM ET

Accepted

May 21, 5:52 PM ET

Size

20.6 KB

Accession

0001415889-25-013978

Insider Transaction Report

Form 4
Period: 2025-05-19
Busque Philippe
SVP, GLOBAL SALES AND SERVICES
Transactions
  • Tax Payment

    Common Stock

    2025-05-19$2.69/sh942$2,53418,917 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-05-191,47325,048 total
    Common Stock (1,473 underlying)
  • Tax Payment

    Common Stock

    2025-05-19$2.69/sh399$1,07316,544 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-05-192,41655,588 total
    Common Stock (2,416 underlying)
  • Exercise/Conversion

    Common Stock

    2025-05-19+1,47318,017 total
  • Tax Payment

    Common Stock

    2025-05-19$2.69/sh574$1,54417,443 total
  • Exercise/Conversion

    Common Stock

    2025-05-19+2,41619,859 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-05-191,02411,786 total
    Common Stock (1,024 underlying)
  • Exercise/Conversion

    Common Stock

    2025-05-19+1,02416,943 total
Footnotes (5)
  • [F1]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Represents the number of shares withheld by and surrendered to the Issuer on May 19, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
  • [F3]The shares subject to the RSU Award shall vest over four years with 13/48 of the total shares underlying the RSU Award vesting on May 18, 2024; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter; and 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter.
  • [F4]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2025 and each March 10 thereafter.
  • [F5]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter, until fully vested.

Issuer

Cytek Biosciences, Inc.

CIK 0001831915

Entity typeother

Related Parties

1
  • filerCIK 0001991396

Filing Metadata

Form type
4
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:52 PM ET
Size
20.6 KB